David A. Siegel Anika Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q4 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 26,283 shares of ANIK stock, worth $465,471. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,283

Previous 39,083 32.75%

Holding current value

$465,471

Previous $965,000 55.23%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$16.04 - $25.53 $205,312 - $326,784	-12,800 Reduced 32.75%	26,283 $432,000
Q3 2024 Nov 14, 2024	SELL	$24.25 - $28.75 $322,525 - $382,375	-13,300 Reduced 25.39%	39,083 $965,000
Q2 2024 Aug 14, 2024	SELL	$24.57 - $28.47 $471,744 - $546,624	-19,200 Reduced 26.82%	52,383 $1.33 Million
Q1 2024 May 15, 2024	BUY	$21.95 - $26.42 $204,135 - $245,706	9,300 Added 14.93%	71,583 $1.82 Million
Q4 2023 Feb 14, 2024	BUY	$18.47 - $23.3 $310,296 - $391,440	16,800 Added 36.94%	62,283 $1.41 Million
Q3 2023 Nov 14, 2023	SELL	$16.98 - $26.1 $427,896 - $657,720	-25,200 Reduced 35.65%	45,483 $847,000
Q2 2023 Aug 14, 2023	SELL	$25.16 - $28.86 $70,448 - $80,808	-2,800 Reduced 3.81%	70,683 $1.84 Million
Q1 2023 May 15, 2023	SELL	$25.91 - $32.1 $331,648 - $410,880	-12,800 Reduced 14.83%	73,483 $2.11 Million
Q4 2022 Feb 14, 2023	BUY	$23.85 - $31.91 $405,450 - $542,470	17,000 Added 24.54%	86,283 $2.55 Million
Q3 2022 Nov 14, 2022	SELL	$21.74 - $24.68 $339,144 - $385,008	-15,600 Reduced 18.38%	69,283 $1.65 Million
Q2 2022 Aug 15, 2022	BUY	$20.4 - $25.53 $330,480 - $413,586	16,200 Added 23.59%	84,883 $1.9 Million
Q1 2022 May 16, 2022	BUY	$24.7 - $36.54 $224,770 - $332,514	9,100 Added 15.27%	68,683 $1.73 Million
Q4 2021 Feb 14, 2022	SELL	$35.83 - $45.03 $150,486 - $189,126	-4,200 Reduced 6.58%	59,583 $2.14 Million
Q3 2021 Nov 15, 2021	SELL	$38.75 - $44.47 $1.71 Million - $1.96 Million	-44,000 Reduced 40.82%	63,783 $2.72 Million
Q2 2021 Aug 16, 2021	BUY	$39.42 - $48.08 $39,420 - $48,080	1,000 Added 0.94%	107,783 $4.67 Million
Q1 2021 May 17, 2021	BUY	$32.49 - $45.96 $779,760 - $1.1 Million	24,000 Added 28.99%	106,783 $4.36 Million
Q4 2020 Feb 16, 2021	SELL	$32.59 - $45.26 $192,281 - $267,034	-5,900 Reduced 6.65%	82,783 $3.75 Million
Q3 2020 Nov 16, 2020	SELL	$32.56 - $38.57 $114,285 - $135,380	-3,510 Reduced 3.81%	88,683 $3.14 Million
Q2 2020 Aug 14, 2020	BUY	$27.83 - $37.73 $13,191 - $17,884	474 Added 0.52%	92,193 $3.48 Million
Q1 2020 May 15, 2020	SELL	$22.38 - $54.06 $534,882 - $1.29 Million	-23,900 Reduced 20.67%	91,719 $2.65 Million
Q4 2019 Feb 14, 2020	SELL	$51.85 - $73.36 $2.25 Million - $3.18 Million	-43,400 Reduced 27.29%	115,619 $6 Million
Q3 2019 Nov 14, 2019	SELL	$40.05 - $57.47 $1.74 Million - $2.49 Million	-43,400 Reduced 21.44%	159,019 $8.73 Million
Q2 2019 Aug 14, 2019	SELL	$30.3 - $41.14 $445,410 - $604,758	-14,700 Reduced 6.77%	202,419 $8.22 Million
Q1 2019 May 15, 2019	BUY	$29.37 - $40.49 $2.69 Million - $3.71 Million	91,700 Added 73.11%	217,119 $6.57 Million
Q4 2018 Feb 14, 2019	SELL	$30.16 - $43.0 $108,576 - $154,800	-3,600 Reduced 2.79%	125,419 $4.22 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $42.51 $476,035 - $616,395	-14,500 Reduced 10.1%	129,019 $5.44 Million
Q2 2018 Aug 14, 2018	BUY	$28.77 - $48.27 $2.26 Million - $3.78 Million	78,400 Added 120.39%	143,519 $4.59 Million
Q1 2018 May 15, 2018	SELL	$49.22 - $68.43 $19,688 - $27,372	-400 Reduced 0.61%	65,119 $3.24 Million
Q4 2017 Feb 14, 2018	SELL	$52.14 - $59.94 $813,384 - $935,064	-15,600 Reduced 19.23%	65,519 $3.53 Million
Q3 2017 Nov 14, 2017	BUY	$51.16 - $58.21 $4.15 Million - $4.72 Million	81,119	81,119 $4.71 Million

Others Institutions Holding ANIK

# of Institutions

111

Shares Held

11.1M

Call Options Held

1.8K

Put Options Held

1.9K

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $259M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account